Column Group L P's Form 4 filing
NGM Biopharmaceuticals Inc (NGM) · filed Jan 26, 2022
- Accession no.
- 0000899243-22-003318
- Filed
- Jan 26, 2022, 7:12 PM ET
- Trade date
- Jan 24-25, 2022
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Not on the form (before 2023)
This filing lists 4 non-derivative transactions. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Column Group L PCIK 0001347769 | Director, 10% Owner |
| Column Group II, LPCIK 0001600420 | 10% Owner |
| Svennilson PeterCIK 0001606074 | 10% Owner |
| Kutzkey TimCIK 0001614186 | 10% Owner |
| Column Group II GP, LPCIK 0001645333 | 10% Owner |
| Column Group Management LPCIK 0001645340 | 10% Owner |
| Ponoi Capital, LPCIK 0001707230 | 10% Owner |
| Ponoi Management, LLCCIK 0001720702 | 10% Owner |
| Ponoi Capital II, LPCIK 0001732601 | 10% Owner |
| Ponoi II Management, LLCCIK 0001746488 | 10% Owner |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Jan 24, 2022 | Common Stock | PPurchaseAcquired | +241,750 | –F1 | – | 241,750 | Indirect | Duplicate filing |
| Jan 24, 2022 | Common Stock | PPurchaseAcquired | +8,250 | –F1 | – | 8,250 | Indirect | Duplicate filing |
| Jan 25, 2022 | Common Stock | PPurchaseAcquired | +579,910 | –F4 | – | 821,660 | Indirect | Duplicate filing |
| Jan 25, 2022 | Common Stock | PPurchaseAcquired | +19,791 | –F4 | – | 28,041 | Indirect | Duplicate filing |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
- F1
Represents a purchase of common stock pursuant to a block trade at a price of $14.64 per share.
Referenced by the price of 2 transactions in Table I.
- F4
Represents a purchase of common stock pursuant to a block trade at a price of $14.30 per share.
Referenced by the price of 2 transactions in Table I.
Remarks
Due to SEC restrictions on the number of reporting owners, this is Form 1 of 2.